Medical equipment industry

Medical equipment industry

The Future of Cardiothoracic Surgery: Navigating Complexity and Innovation

The cardiothoracic specialty is undergoing a significant transformation, driven by complex cardiac disease, increased competition, technological innovation, and financial constraints. As a result, cardiothoracic surgeons must adapt to new market dynamics and adopt innovative treatments, such as ablation for atrial fibrillation and cell therapy for heart failure. This shift requires

Medical equipment industry

TyRx Pharma Receives Equity Investment from Boston Scientific Corporation

TyRx Pharma, Inc., a privately held company specializing in developing proprietary bioresorbable drug-eluting polymers, has secured an equity investment from Boston Scientific Corporation. This partnership marks a significant milestone in their ongoing collaboration, having worked together since 2002 on co-developing drug eluting coatings for cardiovascular stents under a licensing agreement.

Medical equipment industry

Cross-License Agreement Boosts Cardiovascular Medical Device Development

CorMatrix Cardiovascular and Cook Biotech have partnered to facilitate the development of cutting-edge cardiovascular medical devices using proprietary biomaterials. The cross-license agreement enables the Atlanta-based tissue-engineering company to leverage Cook's expertise in manufacturing extracellular matrix (ECM) biomaterials, expanding its product pipeline to treat cardiac tissue diseases. Potential applications